APG Asset Management US’s Edwards Lifesciences EW Stock Holding History

APG Asset Management US’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,449	Closed	-$950K	–	97
2025 Q3	$950K	Hold	12,449	–	–	0.01%	130
2025 Q2	$961K	Hold	12,449	–	–	0.01%	128
2025 Q1	$895K	Hold	12,449	–	–	0.01%	128
2024 Q4	$922K	Sell	12,449 -1,518	-11%	-$106K	0.01%	126
2024 Q3	$909K	Sell	13,967 -162,651	-92%	-$11.8M	0.01%	125
2024 Q2	$15.9M	Buy	176,618 +3,791	+2%	+$336K	0.09%	104
2024 Q1	$16.3M	Buy	172,827 +54,208	+46%	+$4.55M	0.09%	102
2023 Q4	$9.04M	Buy	+118,619	New	+$8.25M	0.06%	109

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

APG Asset Management US's EW Position: Q4 2025 in Review

APG Asset Management US sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 12,449 shares — an estimated $950K sold.

APG Asset Management US first reported a position in EW in Q4 2023 and held it in 8 quarters. The position peaked at $16.3M in Q1 2024. 1,315 funds tracked by Wall St. Rank hold EW as of Q4 2025.

APG Asset Management US reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
APG Asset Management US sold 12,449 Edwards Lifesciences shares in Q4 2025, an estimated $950K.
APG Asset Management US first reported a position in Edwards Lifesciences in Q4 2023 and held it in 8 quarters.
APG Asset Management US's Edwards Lifesciences position peaked at $16.3M in Q1 2024.
1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.